Skip to main content
Published locations for Early myeloablative therapy may benefit subset of high-risk non-Hodgkin’s lymphoma patients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Early myeloablative therapy may benefit subset of high-risk non-Hodgkin’s lymphoma patients
User login
Username
Password
Reset your password
/content/early-myeloablative-therapy-may-benefit-subset-high-risk-non-hodgkins-lymphoma-patients
/oncologypractice/article/78604/lymphoma-plasma-cell-disorders/early-myeloablative-therapy-may
/hematology-oncology/article/78604/lymphoma-plasma-cell-disorders/early-myeloablative-therapy-may